Dear Madam/Sir,
We are very pleased to share with you the latest ECIBC recommendations on breast cancer screening
and diagnosis.
On screening
What is the optimal strategy to invite women to organised breast cancer screening
programmes?
This set of recommendations aims to determine the best way to invite women to attend their
periodic screening.
How should mammography screening be implemented?
This recommendation clarifies that organised screening programmes have greater ability to
cover the target population, greater effectiveness as well as providing a more equitable access to
these services.
How should screening mammographies be read?
Practice varies with respect to image reading and diagnostic protocols. One of the methods that
can be adopted to improve sensitivity of mammography screening is double reading, whereby
the mammograms are read, generally independently, by two trained readers.
On diagnosis
Which method should be used to obtain a sample of a suspicious breast lesion?
Currently, there are two non-operative methods to obtain samples of a breast lesion: fine needle
aspiration cytology and needle core biopsy. This recommendation evaluates these two different
methods.
What threshold of oestrogen and/or progesterone should be used to provide endocrine
therapy in women with invasive cancer?
The hormone receptor status of an invasive breast carcinoma is a strong predictive marker of
tumour response to endocrine therapy. Different thresholds are currently used. The aim of these
questions was to determine the most appropriate threshold to use.
Should Ki-67 testing (in addition to clinico-pathological indices and breast biomarkers) be
used to guide the administration of adjuvant chemotherapy in patients with hormone receptor
positive, HER-2 negative, lymph node negative invasive breast cancer?
The measurement of tumour cell proliferation using the Ki67 index may provide additional
prognostic and predictive information and assist decision making regarding administration of
adjuvant chemotherapy to patients with invasive breast cancer. The aim of this recommendation
was to answer this question.
Background
The European Commission Initiative on Breast Cancer (ECIBC) is developing the European Breast
Guidelines, evidence based recommendations. The European Breast Guidelines provide women and
healthcare providers with clear, objective and independent guidance on breast cancer screening and
diagnosis. They guide healthcare managers and policy-makers in planning, organising and monitoring the
effectiveness of services for breast cancer screening and diagnosis. The recommendations already
available can be found online, and more will be released in the coming months, as soon as they are
finalised.
With thanks and best wishes,
Healthcare Quality / ECIBC Team
European Commission
Directorate General Joint Research Centre
Directorate F – Health, Consumers and Reference Materials
Unit F1 “Health in Society”
via E. Fermi, 2749. TP127, I-21027 Ispra (VA), Italy
[email protected]
ecibc.jrc.ec.europa.eu
If you do not wish to receive information about ECIBC please return email with "Remove from contacts list" in the subject line or
Unsubscribe. Did someone forward this to you? Subscribe to stay informed.
Privacy statement